calendar
30,703 catalysts · 11,098 approval · 5,000 device 510k · 4,728 grant · 3,086 8k filing · 2,000 device pma · 2,000 device recall
30,703 catalysts · 11,098 approval · 5,000 device 510k · 4,728 grant · 3,086 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: CUMBERLAND PHARMS. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: LGM PHARMA. Form: CAPSULE. Route: ORAL
Sponsor: PFIZER. Form: POWDER. Route: INTRAVENOUS
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: ALKERMES. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: ABBVIE INC. Form: VIAL
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
Sponsor: VERTEX PHARMS. Form: TABLET. Route: ORAL
Sponsor: BAYER HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: HALEON US HOLDINGS. Form: SPRAY, METERED. Route: NASAL
Sponsor: PHARMACYCLICS LLC. Form: CAPSULE. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: ORGANON LLC. Form: TABLET. Route: ORAL
Sponsor: TARO. Form: CAPSULE. Route: ORAL
Sponsor: TARO. Form: CAPSULE. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL
Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL
Sponsor: GENUS LIFESCIENCES. Form: SOLUTION. Route: ORAL
Sponsor: TAKEDA PHARMS USA. Form: TABLET. Route: ORAL
Sponsor: AYTU. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL
Sponsor: KENVUE BRANDS. Form: TABLET. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: INJECTABLE. Route: INJECTION
Sponsor: TAKEDA PHARMS USA. Form: TABLET. Route: ORAL
Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL
Sponsor: NEXTWAVE PHARMS. Form: TABLET, EXTENDED RELEASE, CHEWABLE. Route: ORAL
Sponsor: ACTELION. Form: TABLET. Route: ORAL
Sponsor: ACTELION. Form: TABLET. Route: ORAL
Sponsor: TRIS PHARMA INC. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: TAKEDA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: MOLNLYCKE HLTH. Form: SOLUTION. Route: TOPICAL
Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: APOTEX. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: ZYDUS PHARMS USA. Form: TABLET. Route: ORAL